| J Pharm Drug Deliv Res |
| Achievement of a chronological release profile of etodolac from coated bilayer tablets |
Ehab R Bendas, Randa Latif, Ragwa M Farid and Kirolos R Georgy |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| An insight to the molecular interactions of the FDA approved PR drugs against L38L↑N↑L PR mutant |
Zainab K Sanusi, Thavendran Govender, Glenn E M Maguire, Sibusiso B Maseko, Johnson Lin, Hendrik G Kruger and Bahareh Honarparvar |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Biopharmaceutical evaluation of a parenterally injected formulation |
Patricia Sibylle Hegger |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Challenges and opportunities in controlling drug substance properties |
Peter H Karpinski |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Comparison of linear poly ethylene imine (LPEI) and poly l-lysine (PLL) in fabrication of CHOK1 cell-loaded multilayer alginate microcapsules |
Fariba Hajifathaliha, Arash Mahboubi and Leila Nematollahi |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Dermal application of nanostructured lipid carriers containing lidocaine |
Erzsebet Csanyi,A Kovacs, M Budai-Szucs and Sz Berko |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Equilibrium solubility measurements of two carvedilol polymorphs with saturation shake-flask method and with real-time monitoring |
Dora Csicsak,Eniko Jaksa-Borbas, Gergely Volgyi and Krisztina Takacs-Novak |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Hinge region modification in sFLT01 to increase the molecular stability and decrease unwanted immune responses incidence |
Zahra-Soheila Soheili, Fahimeh Zakeri, Mehdi Sadeghi, Shahram Samiei, Ehsan Ranaei Pirmardan, Sepideh Taghizadeh, Hamid Ahmadieh, Maliheh Davari, Hamid Latifi Navid and Ali Hafezi-Moghadam |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Improving biopharmaceutical properties of diacerein using crystal engineering approach |
Rajeshri D Patel, Riddhi H Shukla, Prakruti R Buch, Tejas P Sharma and Mihir K Raval |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| In-situ seeding in batch precipitation and crystallization |
Peter H Karpinski |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| In-vitro anticancer activity of separated fraction from Cassia alata L. on human urinary bladder carcinoma (T24) cell line and Vero cell line (non-transformed-normal cell line) |
Meenakshi Barua |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| KRAS mutation in advanced lung cancer: Response |
Yang Yuan,Ma Qianli |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Methodology of math-physical medicine |
Gerald C Hsu |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Non clinical studies in development of new drug delivery technologies; are they predictive or indicative? |
Bijay Kumar Padhi |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| Novel magnetic delivery systems for platinum anticancer drugs |
Lamis Refaat and Tamer Shoeib |
|
PDF |
HTML
|
| J Pharm Drug Deliv Res |
| SIRT1 siRNA loaded cationic liposomes showed enhanced cell death of prostate cancer cells with different p53 expression patterns |
Bilge Debelec Butuner, Ezgi Oner, Mustafa Kotmakci and Ayse Gulten Kantarci |
|
PDF |
HTML
|
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
